Axsome Therapeutics Q3 EPS $(0.25) Beats $(0.56) Estimate, Sales $259.691M Beat $249.929M Estimate
Benzinga Newsdesk 15 hours ago
NewsEarningsEarnings Beats
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.56) by 55.36 percent. This is a 73.4 percent increase over losses of $(0.94) per share
Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.56) by 55.36 percent. This is a 73.4 percent increase over losses of $(0.94) per share from the same period last year. The company reported quarterly sales of $259.691 million which beat the analyst consensus estimate of $249.929 million by 3.91 percent. This is a 51.87 percent increase over sales of $170.992 million the same period last year.